Related Experiment Videos
Protein carboxyl methylation controls intracellular pH in human platelets
K Otsuka1, C M Roullet, P McDougal
1Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland 97201-3098, USA.
Journal of Hypertension
|September 24, 1998
Summary
Protein carboxyl methylation regulates intracellular pH homeostasis. Inhibiting this process with AFC in human platelets reduces basal pH and alters Na+-H+ antiporter function, impacting cellular pH balance.
Area of Science:
- Cellular Biology
- Biochemistry
- Physiology
Background:
- Carboxyl methylation is a key post-translational modification regulating protein function.
- The human Na+-H+ antiporter (NHE-1) is crucial for maintaining intracellular pH homeostasis.
- NHE-1 contains a consensus sequence for carboxyl methylation, suggesting its regulation by this process.
Purpose of the Study:
- To investigate the role of protein carboxyl methylation in regulating intracellular pH (pHi) in human platelets.
- To determine how inhibiting carboxyl methylation affects the kinetic properties of the Na+-H+ antiporter (NHE-1).
Main Methods:
- Human platelets were treated with N-acetyl-S-trans,trans-farnesyl-L cysteine (AFC), a specific inhibitor of prenylcysteine methyltransferase.
- Intracellular pH (pHi) was measured using a fluorescent pH indicator.
- Na+-H+ antiporter kinetics were analyzed by acidifying platelets and challenging them with varying extracellular sodium concentrations.
Main Results:
- AFC treatment significantly decreased basal pHi in human platelets.
- Inhibition of carboxyl methylation altered the kinetic properties of the Na+-H+ antiporter, including maximal recovery rate and sodium affinity.
- The effects were dose-dependent and specific to Na+-dependent recovery.
Conclusions:
- Carboxyl methylation plays a significant role in regulating intracellular pH homeostasis.
- Inhibition of carboxyl methylation disrupts normal pHi regulation by altering NHE-1 activity.
- These findings highlight carboxyl methylation as a potential target for modulating cellular pH balance.